CluePoints: Launch Post-COVID Trial Assurance Solution
Trial tech provider CluePoints has introduced its Post-COVID Trial Assurance Solution, intended to give study teams the opportunity to assess the quality of their data within a defined timeline and with limited resources. The tool is designed to evaluate clinical data to assess expected risks and at the same time identify anomalies that could indicate unexpected risks.
Patrick Hughes, chief commercial officer and cofounder, said, “Risk-based monitoring remains of central importance to help sponsors and CROs predict and manage risk at an early stage, so that monitoring resources can be prioritized based on actual need.”
